Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8801
Everspin Technologies
MRAM
$460M
| $102K | ﹤0.01% |
14,649
-2,076
| -12% | -$10.2K |
|
|
MRCC
8802
DELISTED
Monroe Capital Corp
MRCC
| $102K | ﹤0.01% |
14,654
-10,959
| -43% | -$80.7K |
|
8803
CALL
Televisa
TV
$1.53B
| $102K | ﹤0.01% |
+19,400
| New | +$107K |
|
8804
CALL
Vermilion Energy
VET
$1.73B
| $102K | ﹤0.01% |
22,800
-22,300
| -49% | -$105K |
|
8805
CALL
Select Water Solutions
WTTR
$2.69B
| $102K | ﹤0.01% |
20,900
-2,400
| -10% | -$11K |
|
8806
PUT
Ardelyx
ARDX
$1.05B
| $101K | ﹤0.01% |
14,600
-8,600
| -37% | -$59.8K |
|
8807
Asure Software
ASUR
$245M
| $101K | ﹤0.01% |
+15,687
| New | +$97.9K |
|
|
CRESY
8808
Cresud
CRESY
$750M
| $101K | ﹤0.01% |
35,567
-5,147
| -13% | -$16.4K |
|
8809
Gilat Satellite Networks
GILT
$887M
| $101K | ﹤0.01% |
15,879
-831
| -5% | -$6.39K |
|
8810
CALL
Global Partners
GLP
$1.72B
| $101K | ﹤0.01% |
+10,300
| New | +$106K |
|
8811
Team
TISI
$101M
| $101K | ﹤0.01% |
1,826
-180
| -9% | -$9.95K |
|
|
AVID
8812
CALL
DELISTED
Avid Technology Inc
AVID
| $101K | ﹤0.01% |
+13,900
| New | +$91.7K |
|
|
FPRX
8813
CALL
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $101K | ﹤0.01% |
16,500
+5,200
| +46% | +$21.4K |
|
8814
Ceragon Networks
CRNT
$200M
| $100K | ﹤0.01% |
46,374
-6,202
| -12% | -$13K |
|
8815
Lineage Cell Therapeutics
LCTX
$271M
| $100K | ﹤0.01% |
114,230
+51,293
| +81% | +$45.1K |
|
8816
PUT
Pitney Bowes
PBI
$2.25B
| $100K | ﹤0.01% |
38,300
-9,100
| -19% | -$22.7K |
|
|
RVLP
8817
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $100K | ﹤0.01% |
14,880
-44,943
| -75% | -$220K |
|
|
IO
8818
DELISTED
ION Geophysical Corporation
IO
| $100K | ﹤0.01% |
+42,818
| New | +$93.5K |
|
8819
PUT
Fennec Pharmaceuticals
FENC
$411M
| $99K | ﹤0.01% |
+11,800
| New | +$87.8K |
|
8820
PUT
Geron
GERN
$943M
| $99K | ﹤0.01% |
45,400
+11,700
| +35% | +$17.5K |
|
8821
CALL
iHeartMedia
IHRT
$457M
| $99K | ﹤0.01% |
+11,800
| New | +$91.9K |
|
8822
Marker Therapeutics
MRKR
$19M
| $99K | ﹤0.01% |
4,768
-1,612
| -25% | -$35.3K |
|
8823
CALL
Newmark Group
NMRK
$2.76B
| $99K | ﹤0.01% |
+20,300
| New | +$85.3K |
|
8824
Quantum Corp
QMCO
$1.03B
| $99K | ﹤0.01% |
1,279
-486
| -28% | -$38.5K |
|
|
GRCE
8825
Grace Therapeutics
GRCE
$45.4M
| $99K | ﹤0.01% |
4,380
+2,876
| +191% | +$83.9K |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.